Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Attenuation of HOIL-1L ligase activity promotes systemic autoimmune disorders by augmenting linear ubiquitin signaling
Yasuhiro Fuseya, Keiichiro Kadoba, Xiaoxi Liu, Hiroyuki Suetsugu, Takeshi Iwasaki, Koichiro Ohmura, Takayuki Sumida, Yuta Kochi, Akio Morinobu, Chikashi Terao, Kazuhiro Iwai
Yasuhiro Fuseya, Keiichiro Kadoba, Xiaoxi Liu, Hiroyuki Suetsugu, Takeshi Iwasaki, Koichiro Ohmura, Takayuki Sumida, Yuta Kochi, Akio Morinobu, Chikashi Terao, Kazuhiro Iwai
View: Text | PDF
Research Article Cell biology

Attenuation of HOIL-1L ligase activity promotes systemic autoimmune disorders by augmenting linear ubiquitin signaling

  • Text
  • PDF
Abstract

Linear ubiquitin chains, which are generated specifically by the linear ubiquitin assembly complex (LUBAC) ubiquitin ligase, play crucial roles in immune signaling, including NF-κB activation. LUBAC comprises catalytic large isoform of heme-oxidized iron regulatory protein 2 ubiquitin ligase 1 (HOIL-1L) interacting protein (HOIP), accessory HOIL-1L, and SHANK-associated RH domain-interacting protein (SHARPIN). Deletion of the ubiquitin ligase activity of HOIL-1L, an accessory ligase of LUBAC, augments LUBAC functions by enhancing LUBAC-mediated linear ubiquitination, which is catalyzed by HOIP. Here, we show that HOIL-1L ΔRING1 mice, which exhibit augmented LUBAC functions upon loss of the HOIL-1L ligase, developed systemic lupus erythematosus (SLE) and Sjögren’s syndrome in a female-dominant fashion. Augmented LUBAC activity led to hyperactivation of both lymphoid and myeloid cells. In line with the findings in mice, we sought to identify missense single nucleotide polymorphisms/variations of the RBCK1/HOIL-1L gene in humans that attenuate HOIL-1L ligase activity. We found that the R464H variant, which is encoded by rs774507518 within the RBCK1/HOIL-1L gene, attenuated HOIL-1L ligase activity and augmented LUBAC-mediated immune signaling, including that mediated by Toll-like receptors. We also found that rs774507518 was enriched significantly in patients with SLE, strongly suggesting that RBCK1/HOIL-1L is an SLE susceptibility gene and that augmented linear ubiquitin signaling generated specifically by LUBAC underlies the pathogenesis of this prototype systemic autoimmune disease.

Authors

Yasuhiro Fuseya, Keiichiro Kadoba, Xiaoxi Liu, Hiroyuki Suetsugu, Takeshi Iwasaki, Koichiro Ohmura, Takayuki Sumida, Yuta Kochi, Akio Morinobu, Chikashi Terao, Kazuhiro Iwai

×

Figure 6

The HOIL-1L R464H variant shows reduced E3 activity to trigger formation of LUBAC-mediated linear ubiquitin chains.

Options: View larger image (or click on image) Download as PowerPoint
The HOIL-1L R464H variant shows reduced E3 activity to trigger formation...
(A and C) Schematic representation of HOIL-1L and the Petit-SHARPIN domains and the experimental protocols for D. (B) Auto-monoubiquitination of HOIL-1L in the presence of the indicated recombinant HOIL-1L and Myc-tagged ubiquitin. (D) Generation of linear ubiquitin chains in the presence of the indicated recombinant proteins in in vitro ubiquitination assays. (E and K) Lysates from LUBAC-TKO MEFs stably reconstituted with the indicated proteins were probed as indicated. (F) Stability of HOIL-1L, p62, and IκBα in LUBAC-TKO MEFs expressing the indicated proteins and treated with CHX (20 mg/mL). (G) Lysates from LUBAC-TKO MEFs stably reconstituted with the indicated proteins, then stimulated with TNF-α (1 ng/mL) and CHX (20 mg/mL), were probed as indicated. (H) Cell death of LUBAC-TKO MEFs stably reconstituted with HOIP, SHARPIN, and HOIL-1L, followed by TNF-α (10 ng /mL) and CHX (20 mg/mL), was monitored by measuring lactate dehydrogenase (LDH) activity. Mean values (n = 3) are shown. (I) Viability of LUBAC-TKO MEFs stably reconstituted with HOIP, SHARPIN, and HOIL-1L (as indicated), then stimulated with TNF-α (40 ng/mL), was measured using the iCELLigence. (J) NF-κB activation in HEK293T cells transfected with the indicated expression plasmids was measured in a luciferase assay. Mean values (n = 6) ± SD are shown. (L and M) Stability of IκBα in LUBAC-TKO MEFs expressing the indicated proteins and treated with CHX (20 mg/mL). Data are expressed as the mean (n = 3) ± SD. (N) QPCR analysis of TKO MEFs stably reconstituted with the indicated proteins. Mean values (n = 3) ± SD are shown. (H, J, M, and N) P values were calculated by Dunnett’s multiple comparisons test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts